The shares of Colgate-Palmolive Company (NYSE:CL) has been pegged with a rating of Neutral by JP Morgan in its latest research note that was published on April 29th, 2019. The research company has also assigned a $70 price target. JP Morgan wasn’t the only research firm that published a report of Colgate-Palmolive Company, with other equities research analysts also giving their opinion on the stock. Credit Suisse advised investors in its research note published on March 7th, 2019, to Underperform the CL stock. The stock had earned Neutral rating from Exane BNP Paribas when it published its report on February 11th, 2019. That day the Exane BNP Paribas set price target on the stock to $67. The stock was given Outperform rating by Evercore ISI in its report released on January 11th, 2019, the day when the price target on the stock was placed at $70. Goldman was of a view that CL is Buy in its latest report on January 9th, 2019. JP Morgan thinks that CL is worth Underweight rating. This was contained in the firm’s report on October 29th, 2018.

Amongst the analysts that rated the stock, 1 have recommended investors to sell it, 14 believe it has the potential for further growth, thus rating it as Hold while 3 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $70.02. The price of the stock the last time has raised by 23.93% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 57.18.

The shares of the company dipped by -0.57% during the trading session on Tuesday, reaching a low of $71.13 while ending the day at $71.15. During the trading session, a total of 2.82 million shares were traded which represents a 14.41% incline from the average session volume which is 3.30M shares. CL had ended its last session trading at 71.56. Colgate-Palmolive Company currently has a market cap of $61.33B, while its P/E ratio stands at 25.70, while its P/E earnings growth sits at 3.98, with a beta of 0.80. CL 52-week low price stands at $57.41 while its 52-week high price is $72.85.

The company in its last quarterly report recorded $0.67 earnings per share which is above the $0.66 predicted by most analysts. The Colgate-Palmolive Company generated $3,884.00 million in revenue during the last quarter, which is slightly higher than the $3,858.57 million predicted by analysts. In the second quarter last year, the firm recorded $0.74 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -10.45%. Colgate-Palmolive Company has the potential to record 2.77 EPS for the current fiscal year, according to equities analysts.

Investment analysts at Robert W. Baird published a research note on February 25th, 2019 where it informed investors and clients that VEREIT, Inc. (NYSE:VER) is now rated as Neutral. Their price target on the stock stands at $9. Credit Suisse also rated VER as Initiated on March 7th, 2019, with its price target of $140 suggesting that VER could surge by 0.82% from its current share price. Even though the stock has been trading at $8.47/share, analysts expect it to surge higher by 0.47% to reach $8.58/share. It started the day trading at $8.54 and traded between $8.44 and $8.51 throughout the trading session.

A look at its technical shows that VER’s 50-day SMA is 8.27 while its 200-day SMA stands at 7.78. At the moment, only of VEREIT, Inc. shares were sold short. The company’s average trading volume currently stands at 7.62M shares, which means that the short-interest ratio is just 3.28 days. Over the past seven days, the company moved, with its shift of 3.91%. Looking further, the stock has raised 2.78% over the past 90 days while it gained 11.24% over the last six months.

The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more VER shares, increasing its portfolio by +1.54% during the last quarter. This move now sees The Vanguard Group Inc purchasing 1,980,582 shares in the last quarter, thus it now holds 130,204,238 shares of VER, with a total valuation of $1,075,487,006. Cohen Steers Capital Management meanwhile bought more VER shares in the recently filed quarter, changing its stake to $805,988,622 worth of shares. BlackRock Fund Advisors followed the path by increasing its VER portfolio by +0.10% in the quarter. This means that BlackRock Fund Advisors bought 56,424 shares in the last quarter and now controls 58,564,436 shares of the VER stock, with the valuation hitting $483,742,241.

Similarly, SSgA Funds Management Inc increased its VEREIT, Inc. shares by +1.13% during the recently filed quarter. After buying 356,353 shares in the last quarter, the firm now controls 31,867,643 shares of VEREIT, Inc. which are valued at $263,226,731. In the same vein, Daiwa Asset Management Co Ltd increased its VEREIT, Inc. shares by during the most recent reported quarter. The firm bought 4,096,125 shares during the quarter which increased its stakes to 27,358,073 shares and is now valued at $225,977,683. Following these latest developments, around 0.50% of VEREIT, Inc. stocks are owned by institutional investors and hedge funds.